版本:
中国

BRIEF-Redhill Biopharma to allow multiple sclerosis patent in Japan

Oct 18 Redhill Biopharma Ltd -

* Redhill Biopharma announces allowance of a patent in Japan supporting RHB-104 for multiple sclerosis

* Top-line final results expected in coming weeks from phase IIA proof-of-concept study evaluating RHB-104

* Safety-Focused independent data and safety monitoring board meeting is on track to take place in Q4 of 2016 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐